← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

M

$ Value

$0

Shares

175

Price

$0

Filed

Oct 8

Insider

Name

Megna Michael R

Title

CHIEF ACCOUNTING OFFICER

CIK

0001464583

Roles

Officer

Transaction Details

Transaction Date

2025-10-04

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. | The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021.

Filing Info

Accession No.

0001464583-25-000003

Form Type

4

Issuer CIK

0001730430

Megna Michael R's History

Date Ticker Type Value
2026-04-09 KNSA $309K
2026-04-07 KNSA M $4K
2026-04-07 KNSA F $82K
2026-04-07 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $154K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA M $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07